Personal Injury
PhRMA’s Drug Pricing Suit Loss Mitigated by Jurisdictional Focus
The leading pharmaceutical industry group has received a setback with the dismissal of its lawsuit challenging a government price-setting program. However, the...
Personal Injury
Growing Resistance Emerges Against Biden’s Proposal to Take Control of Drug Patents
The pharmaceutical industry, Trump and Obama administration officials, and others are urging the Biden administration to reconsider a controversial plan for seizing...
Personal Injury
Pharmaceutical CEOs Indicate Resistance to Price Reductions in Sanders Confrontation
CEOs of Bristol Myers Squibb Co., Johnson & Johnson, and Merck & Co. all declined to commit to lowering the...
Personal Injury
Johnson & Johnson Case Indicates More Employee Drug Price Lawsuits On the Horizon
A lawsuit by an employee suing Johnson & Johnson Inc. for allegedly mismanaging drug benefits is a sign of potential future litigation against companies...
Personal Injury
Conservative States Stand Firm in Bid to Join Supreme Court Abortion Pill Case
Three conservative-led states – Idaho, Missouri, and Kansas – are pushing back against the Biden administration’s efforts to prevent them from participating...
Personal Injury
Lawsuits Take Aim at Flawed Medicare Managed Care Bonus Program
The debate on whether to repair or replace the flawed bonus payment program for Medicare managed care plans has been reignited by a pair...
Personal Injury
Strain State Budgets in Battle Against Obesity with Ozempic and Wegovy
Blockbuster anti-obesity medications are straining the budgets of state health plans and Medicaid programs—a growing problem analysts and researchers say requires more...
Personal Injury
Start of Medicare’s Drug Price Negotiation Period Accompanied by Lawsuits (1)
The Medicare agency will send an initial offer of the maximum fair price to manufacturers with drugs selected in the...